Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
8m agoreAlpha (NASDAQ: AIRE) Announces 1-for-25 Reverse Stock Split to be Effective on April 30, 2026
8m agoEdible Garden Named Among Top 25 Greenhouse Produce Growers in the U.S. in 2026
8m agoRising uncertainty reshapes reputational risk, but organisations hold firm on controls, says Willis
9m agoRedCloud Unveils Specialist AI Agents Trained on $6.9 Billion FMCG Trade Dataset — Targeted to Improve Thousands of Commercial Decisions Daily
9m agoFood Metal Cans Markets, 2025-2030 with Ball Corp, Crown Holdings, Silgan, Ardagh Group, and CCL Industries Dominating
Pmv Pharmaceuticals Inc logo

Pmv Pharmaceuticals Inc

About

Pmv Pharmaceuticals Inc (NASDAQ:PMVP) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
PMV Pharmaceuticals Announces Board Chair Transition
Mar 6 2026
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Feb 26 2026
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Nov 12 2025
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
Oct 24 2025
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

Financials

Revenue
$0
Market Cap
$69.33 M
EPS
-1.48

Community Chat

Ask AI

6ix6ixAIEvents